Insiders · EFTR

EFTR insider transactions

eFFECTOR Therapeutics Inc. (EFTR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

EFTR insiders

Everyone who has filed a Form 3, 4, 5 or 144 at eFFECTOR Therapeutics Inc., latest first. Follow anyone to get their next filing.

• Caroline M LoewyDirector, since September 2023
• Barbara KlenckeDirector, since November 2021
• Christopher B EhrlichDirector+$90.7K
• Kristen Harrington-SmithDirector, since February 2022
• Brian M. Gallagher Jr.Director+$47.7K
• Elizabeth BhattDirector
• Michael ByrnesChief Financial Officer+$33.3K
• Stephen T WorlandChief Executive Officer, Director+$27.4K
• Douglas J WarnerChief Medical Officer, since August 2022
• Sr One Capital Management, LLC10% owner-$369K
• John W SmitherDirector
• Mayank GandhiOfficer, since September 2022
• Carlyle Group Inc.10% owner, since August 2022
• Presidio Management Group X LLC10% owner-$3M
• Alana B. McNultyOfficer
• Premal PatelOfficer
• LLP Abingworth10% owner
• Jonathan D RootDirector, 10% owner-$2.48M

Recent Form 3, 4, and 5 filings for EFTR

• 878d
  SEC Form 4 filed by Director Loewy Caroline M

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 878d
  SEC Form 4 filed by Director Klencke Barbara

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 878d
  SEC Form 4 filed by Director Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 878d
  SEC Form 4 filed by Director Harrington-Smith Kristen

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 878d
  SEC Form 4 filed by Director Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 878d
  SEC Form 4 filed by Director Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 905d
  Byrnes Michael was granted 1,387 shares, increasing direct ownership by 80% to 3,117 units (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 905d
  Worland Stephen T was granted 1,806 shares, increasing direct ownership by 17% to 12,494 units (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 991d
  SEC Form 4 filed by Loewy Caroline M

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 991d
  SEC Form 4 filed by Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 991d
  SEC Form 4 filed by Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 991d
  SEC Form 4 filed by Klencke Barbara

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 991d
  SEC Form 4 filed by Harrington-Smith Kristen

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 991d
  SEC Form 4 filed by Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 991d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 991d
  SEC Form 4 filed by Warner Douglas J

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 991d
  SEC Form 4 filed by Worland Stephen T

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1075d
  Sr One Capital Management, Llc sold $369,457 worth of shares (609,163 units at $0.61) (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1088d
  Worland Stephen T was granted 5,979 shares, increasing direct ownership by 2% to 267,204 units (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1088d
  Byrnes Michael was granted 4,524 shares, increasing direct ownership by 12% to 43,271 units (SEC Form 4)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1154d
  SEC Form 4 filed by Loewy Caroline M

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1154d
  SEC Form 3: New insider Loewy Caroline M claimed ownership of 9,047 shares

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1183d
  SEC Form 4: Worland Stephen T exercised 33,799 shares at a strike of $0.52, increasing direct ownership by 15% to 261,225 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1235d
  SEC Form 4 filed by Smither John W

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1235d
  SEC Form 4 filed by Klencke Barbara

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1235d
  SEC Form 4 filed by Harrington-Smith Kristen

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1235d
  SEC Form 4 filed by Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1235d
  SEC Form 4 filed by Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1235d
  SEC Form 4 filed by Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1273d
  SEC Form 4 filed by Worland Stephen T

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1273d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1384d
  SEC Form 4 filed by Gallagher Brian M. Jr.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1384d
  SEC Form 4 filed by Smither John W

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1384d
  SEC Form 4 filed by Harrington-Smith Kristen

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1384d
  SEC Form 4 filed by Klencke Barbara

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1384d
  SEC Form 4 filed by Ehrlich Christopher B

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1384d
  SEC Form 4 filed by Bhatt Elizabeth

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1389d
  SEC Form 4 filed by Worland Stephen T

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1389d
  SEC Form 4 filed by Warner Douglas J

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1389d
  SEC Form 4 filed by Gandhi Mayank

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1389d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1453d
  SEC Form 4: Byrnes Michael was granted 4,651 shares, increasing direct ownership by 16% to 33,884 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1453d
  SEC Form 4: Worland Stephen T was granted 6,047 shares, increasing direct ownership by 3% to 221,025 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1495d
  SEC Form 4: Ehrlich Christopher B bought $197 worth of shares (346 units at $0.57), increasing direct ownership by 0.99% to 35,213 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1502d
  SEC Form 4 filed by Gandhi Mayank

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1502d
  SEC Form 3 filed by new insider Gandhi Mayank

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1504d
  SEC Form 4: Ehrlich Christopher B bought $10,377 worth of shares (18,867 units at $0.55), increasing direct ownership by 118% to 34,867 units

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1550d
  SEC Form 3: New insider Carlyle Group Inc. claimed ownership of 4,822,114 shares

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1553d
  SEC Form 4 filed by Warner Douglas J

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1553d
  SEC Form 3 filed by new insider Warner Douglas J

  3 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1558d
  SEC Form 4: Presidio Management Group X Llc sold $91,203 worth of shares (114,280 units at $0.80)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1563d
  SEC Form 4: Presidio Management Group X Llc sold $29,005 worth of shares (32,517 units at $0.89)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1565d
  SEC Form 4: Presidio Management Group X Llc sold $43,580 worth of shares (48,719 units at $0.89)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1570d
  SEC Form 4: Presidio Management Group X Llc sold $19,514 worth of shares (20,309 units at $0.96)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1573d
  SEC Form 4: Presidio Management Group X Llc sold $76,278 worth of shares (69,641 units at $1.10)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1596d
  SEC Form 4: Gallagher Brian M. Jr. bought $47,700 worth of shares (30,000 units at $1.59)

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1600d
  SEC Form 4 filed by Mcnulty Alana B.

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1600d
  SEC Form 4 filed by Byrnes Michael

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1600d
  SEC Form 4 filed by Worland Stephen T

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)
• 1609d
  SEC Form 4 filed by Smither John W

  4 - eFFECTOR Therapeutics, Inc. (0001828522) (Issuer)